It is unsafe to consume alcohol with Imuzinc Syrup.
Imuzinc Syrup is safe to use during pregnancy. Most studies have shown low or no risk to the developing baby.
Imuzinc Syrup is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby.
It is not known whether Imuzinc Syrup alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Imuzinc Syrup should be used with caution in patients with kidney disease. Dose adjustment of Imuzinc Syrup may be needed. Please consult your doctor.
Imuzinc Syrup is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Imuzinc Syrup may not be needed in these patients. Please consult your doctor.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More